David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Plug Power
PLUG
$3.03B
| $9.16M | 0.01% |
4,533,789
-769,329
| -15% | -$1.5M |
|
|
ACH
1102
Accendra Health
ACH
$89.2M
| $9.15M | 0.01% |
547,843
-225,209
| -29% | -$3.65M |
|
|
ELP
1103
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $9.14M | 0.01% |
4,095,653
+503,393
| +14% | +$1.36M |
|
1104
Plains GP Holdings
PAGP
$5.4B
| $9.11M | 0.01% |
381,071
+167,385
| +78% | +$4.1M |
|
1105
CALL
Kraft Heinz
KHC
$30.4B
| $9.11M | 0.01% |
+145,000
| New | +$8.6M |
|
1106
Maximus
MMS
$3.05B
| $9.09M | 0.01% |
146,275
+33,869
| +30% | +$2.2M |
|
1107
The Greenbrier Companies
GBX
$1.43B
| $9.08M | 0.01% |
172,203
-22,784
| -12% | -$1.09M |
|
|
DRE
1108
DELISTED
Duke Realty Corp.
DRE
| $9.08M | 0.01% |
312,907
-295,082
| -49% | -$8.14M |
|
|
INFN
1109
DELISTED
Infinera Corporation Common Stock
INFN
| $9.07M | 0.01% |
913,670
-131,624
| -13% | -$1.37M |
|
1110
Expedia Group
EXPE
$40.7B
| $9.04M | 0.01% |
75,234
-99,398
| -57% | -$11.5M |
|
|
GCI
1111
DELISTED
Gannett Co., Inc
GCI
| $9.04M | 0.01% |
845,042
+727,737
| +620% | +$7.53M |
|
1112
New York Times
NYT
$10.9B
| $9.04M | 0.01% |
+349,018
| New | +$8.22M |
|
1113
CALL
Intuit
INTU
$101B
| $9.03M | 0.01% |
+44,200
| New | +$8.48M |
|
|
FIT
1114
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $9.03M | 0.01% |
1,382,245
+909,467
| +192% | +$5.2M |
|
1115
AngloGold Ashanti
AU
$60.9B
| $9.03M | 0.01% |
1,099,304
+585,996
| +114% | +$5.13M |
|
1116
Immersion
IMMR
$250M
| $9.02M | 0.01% |
584,394
+554,594
| +1,861% | +$7.43M |
|
|
BNCL
1117
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $9.01M | 0.01% |
556,117
+8,623
| +2% | +$140K |
|
1118
Regis Corp
RGS
$67M
| $9M | 0.01% |
27,198
-1,518
| -5% | -$495K |
|
|
CLVS
1119
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.98M | 0.01% |
197,400
+9,800
| +5% | +$477K |
|
|
SPPI
1120
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $8.97M | 0.01% |
427,847
-942,770
| -69% | -$17.5M |
|
1121
PUT
Weibo
WB
$1.72B
| $8.95M | 0.01% |
100,800
+50,800
| +102% | +$5.52M |
|
1122
CALL
United Airlines
UAL
$36.9B
| $8.94M | 0.01% |
128,200
+51,800
| +68% | +$3.6M |
|
|
DISCK
1123
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $8.94M | 0.01% |
350,420
-343,186
| -49% | -$7.65M |
|
1124
Globe Life
GL
$13.3B
| $8.93M | 0.01% |
109,687
-71,663
| -40% | -$6.09M |
|
1125
PUT
Humana
HUM
$46.4B
| $8.93M | 0.01% |
30,000
| – | – |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.